Scaldaferri F - Search Results

1

Ecology and Machine Learning-Based Classification Models of Gut Microbiota and Inflammatory Markers May Evaluate the Effects of Probiotic Supplementation in Patients Recently Recovered from COVID-19.

Laterza L, Putignani L, Settanni CR, Petito V, Varca S, De Maio F, Macari G, Guarrasi V, Gremese E, Tolusso B, Wlderk G, Pirro MA, Fanali C, Scaldaferri F, Turchini L, Amatucci V, Sanguinetti M, Gasbarrini A. Laterza L, et al. Among authors: scaldaferri f. Int J Mol Sci. 2023 Apr 1;24(7):6623. doi: 10.3390/ijms24076623. Int J Mol Sci. 2023. PMID: 37047594 Free PMC article.

2

Platelets: new players in the mucosal scenario of inflammatory bowel disease.

Danese S, Scaldaferri F, Papa A, Pola R, Sans M, Gasbarrini G, Pola P, Gasbarrini A. Danese S, et al. Among authors: scaldaferri f. Eur Rev Med Pharmacol Sci. 2004 Sep-Oct;8(5):193-8. Eur Rev Med Pharmacol Sci. 2004. PMID: 15638229 Review.

3

A novel pathogenic role for microvasculature in inflammatory bowel disease.

Danese S, Papa A, Scaldaferri F, Graziani C, Bonizzi M, Armuzzi A, Fedeli G, Gasbarrini G, Gasbarrini A. Danese S, et al. Among authors: scaldaferri f. Eur Rev Med Pharmacol Sci. 2006 Jan-Feb;10(1):3-5. Eur Rev Med Pharmacol Sci. 2006. PMID: 16494103

4

Molecular signaling blockade as a new approach to inhibit leukocyte-endothelial interactions for inflammatory bowel disease treatment.

Scaldaferri F, Correale C, Gasbarrini A, Danese S. Scaldaferri F, et al. Cell Adh Migr. 2009 Jul-Sep;3(3):296-9. doi: 10.4161/cam.3.3.9152. Epub 2009 Jul 2. Cell Adh Migr. 2009. PMID: 19571660 Free PMC article.

5

Mucosal biomarkers in inflammatory bowel disease: key pathogenic players or disease predictors?

Scaldaferri F, Correale C, Gasbarrini A, Danese S. Scaldaferri F, et al. World J Gastroenterol. 2010 Jun 7;16(21):2616-25. doi: 10.3748/wjg.v16.i21.2616. World J Gastroenterol. 2010. PMID: 20518083 Free PMC article. Review.

6

Use and indications of cholestyramine and bile acid sequestrants.

Scaldaferri F, Pizzoferrato M, Ponziani FR, Gasbarrini G, Gasbarrini A. Scaldaferri F, et al. Intern Emerg Med. 2013 Apr;8(3):205-10. doi: 10.1007/s11739-011-0653-0. Epub 2011 Jul 8. Intern Emerg Med. 2013. PMID: 21739227 Review.

7

Bacterial flora as a cause or treatment of chronic diarrhea.

Scaldaferri F, Pizzoferrato M, Pecere S, Forte F, Gasbarrini A. Scaldaferri F, et al. Gastroenterol Clin North Am. 2012 Sep;41(3):581-602. doi: 10.1016/j.gtc.2012.06.002. Epub 2012 Jul 23. Gastroenterol Clin North Am. 2012. PMID: 22917165 Review.

8

The gut barrier: new acquisitions and therapeutic approaches.

Scaldaferri F, Pizzoferrato M, Gerardi V, Lopetuso L, Gasbarrini A. Scaldaferri F, et al. J Clin Gastroenterol. 2012 Oct;46 Suppl:S12-7. doi: 10.1097/MCG.0b013e31826ae849. J Clin Gastroenterol. 2012. PMID: 22955350 Review.

9

Propionyl-L-carnitine hydrochloride for treatment of mild to moderate colonic inflammatory bowel diseases.

Merra G, Gasbarrini G, Laterza L, Pizzoferrato M, Poscia A, Scaldaferri F, Arena V, Fiore F, Cittadini A, Sgambato A, Franceschi F, Gasbarrini A. Merra G, et al. Among authors: scaldaferri f. World J Gastroenterol. 2012 Sep 28;18(36):5065-71. doi: 10.3748/wjg.v18.i36.5065. World J Gastroenterol. 2012. PMID: 23049215 Free PMC article.

10

Pre- and posttherapy assessment of intestinal soluble mediators in IBD: where we stand and future perspectives.

Scaldaferri F, Petito V, Lopetuso L, Bruno G, Gerardi V, Ianiro G, Sgambato A, Gasbarrini A, Cammarota G. Scaldaferri F, et al. Mediators Inflamm. 2013;2013:391473. doi: 10.1155/2013/391473. Epub 2013 May 8. Mediators Inflamm. 2013. PMID: 23737647 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

242 results

Search Page

Filters